{"DataElement":{"publicId":"6118212","version":"1","preferredName":"Vascular Thrombosis Response Evaluation Status","preferredDefinition":"Text term that represents the evaluation of response status for vascular thrombosis.","longName":"VAS_THRB_RSP_EVAL_ST","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"6118202","version":"1","preferredName":"Vascular Thrombosis Disease Response Evaluation","preferredDefinition":"The formation of a blood clot in the lumen of a vessel; causes include coagulation disorders, and vascular endothelial injury._The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","longName":"6118199v1.0:6118200v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"6118199","version":"1","preferredName":"Vascular Thrombosis","preferredDefinition":"The formation of a blood clot in the lumen of a vessel; causes include coagulation disorders, and vascular endothelial injury.","longName":"C114397","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vascular Thrombosis","conceptCode":"C114397","definition":"The formation of a blood clot in the lumen of a vessel; causes include coagulation disorders, and vascular endothelial injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66EE8121-3F29-01B4-E053-F662850AB193","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-08","modifiedBy":"ONEDATA","dateModified":"2018-03-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6118200","version":"1","preferredName":"Disease Response Evaluation","preferredDefinition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.:Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","longName":"C50995:C25214","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66EE8121-3F37-01B4-E053-F662850AB193","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-08","modifiedBy":"ONEDATA","dateModified":"2018-03-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Princess Margaret Cancer Centre, Toronto, ON","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66EE8121-3F48-01B4-E053-F662850AB193","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-08","modifiedBy":"COOPERM","dateModified":"2018-03-27","changeDescription":"Created for CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6118204","version":"1","preferredName":"Thrombosis Response Status","preferredDefinition":"A condition or state at a particular time.","longName":"THROMB_RESP_STS","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"irSD thrombosis","valueDescription":"irSD Thrombosis","ValueMeaning":{"publicId":"6118205","version":"1","preferredName":"irSD Thrombosis","longName":"6118205","preferredDefinition":"Any of a) no change or small changes that do not meet the criteria for irPR or irPD, taking as reference the smallest sum diameters while on study, b) increase in the volume of non-enhancing thrombosis, c) new bland non-enhancing thrombosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"irSD Thrombosis","conceptCode":"C147913","definition":"Any of a) no change or small changes that do not meet the criteria for irPR or irPD, taking as reference the smallest sum diameters while on study, b) increase in the volume of non-enhancing thrombosis, c) new bland non-enhancing thrombosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66EEA017-C745-5C51-E053-F662850AB7E9","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-08","modifiedBy":"COOPERM","dateModified":"2021-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66EEA017-C75E-5C51-E053-F662850AB7E9","beginDate":"2018-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-08","modifiedBy":"ONEDATA","dateModified":"2018-03-08","deletedIndicator":"No"},{"value":"irPD thrombosis","valueDescription":"irPD Thrombosis","ValueMeaning":{"publicId":"6118206","version":"1","preferredName":"irPD Thrombosis","longName":"6118206","preferredDefinition":"Any unequivocal, unambiguous increase in the volume of new or existing enhancing thrombosis. Unequivocal progression of thrombosis corresponds to at least 73% increase in volume, which is similar to 20% increase in diameter, and at least a 5 mm absolute increase.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"irPD Thrombosis","conceptCode":"C147912","definition":"Any unequivocal, unambiguous increase in the volume of new or existing enhancing thrombosis. Unequivocal progression of thrombosis corresponds to at least 73% increase in volume, which is similar to 20% increase in diameter, and at least a 5 mm absolute increase.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66EEA017-C768-5C51-E053-F662850AB7E9","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-08","modifiedBy":"COOPERM","dateModified":"2021-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66EEA017-C781-5C51-E053-F662850AB7E9","beginDate":"2018-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-08","modifiedBy":"ONEDATA","dateModified":"2018-03-08","deletedIndicator":"No"},{"value":"irPR thrombosis","valueDescription":"irPR Thrombosis","ValueMeaning":{"publicId":"6118207","version":"1","preferredName":"irPR Thrombosis","longName":"6118207","preferredDefinition":"Any of a) partial recanalization of thrombosis (if prior complete blockage), b) unequivocal reduction in the maximal girth of thrombosis, c) unequivocal reduction in the volume, or elimination, of arterial enhancing portion of thrombosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"irPR Thrombosis","conceptCode":"C147911","definition":"Any of a) partial recanalization of thrombosis (if prior complete blockage), b) unequivocal reduction in the maximal girth of thrombosis, c) unequivocal reduction in the volume, or elimination, of arterial enhancing portion of thrombosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66EEA017-C78B-5C51-E053-F662850AB7E9","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-08","modifiedBy":"COOPERM","dateModified":"2021-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66EEA017-C7A4-5C51-E053-F662850AB7E9","beginDate":"2018-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-08","modifiedBy":"ONEDATA","dateModified":"2018-03-08","deletedIndicator":"No"},{"value":"irCR thrombosis","valueDescription":"irCR Thrombosis","ValueMeaning":{"publicId":"6118208","version":"1","preferredName":"irCR Thrombosis","longName":"6118208","preferredDefinition":"Complete resolution of thrombosis, with recanalization of vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"irCR Thrombosis","conceptCode":"C147910","definition":"Complete resolution of thrombosis, with recanalization of vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66EEA017-C7AE-5C51-E053-F662850AB7E9","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-08","modifiedBy":"COOPERM","dateModified":"2021-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66EEA017-C7C7-5C51-E053-F662850AB7E9","beginDate":"2018-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-08","modifiedBy":"ONEDATA","dateModified":"2018-03-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Princess Margaret Cancer Centre, Toronto, ON","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66EEA017-C72F-5C51-E053-F662850AB7E9","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-08","modifiedBy":"COOPERM","dateModified":"2021-03-31","changeDescription":"Created for CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Vascular Thrombosis Response","type":"Preferred Question Text","description":"Vascular Thrombosis Response Evaluation","url":null,"context":"NCIP"}],"origin":"Princess Margaret Cancer Centre, Toronto, ON","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66EE823E-5A06-4E0B-E053-F662850A6D41","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-08","modifiedBy":"COOPERM","dateModified":"2018-03-27","changeDescription":"Created for CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}